Seres Therapeutics
MCRB
#8492
Rank
โ‚ฌ0.14 B
Marketcap
0,82ย โ‚ฌ
Share price
-2.31%
Change (1 day)
-20.58%
Change (1 year)

EPS for Seres Therapeutics (MCRB)

EPS in 2023 (TTM): -1,04ย โ‚ฌ

According to Seres Therapeutics's latest financial reports the company's current EPS (TTM) is -1,07ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -2,24ย โ‚ฌ a decrease over its 2021 EPS that were of -0,70ย โ‚ฌ.

EPS history for Seres Therapeutics from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-1,04ย โ‚ฌ-53.4%
2022-2,24ย โ‚ฌ220.55%
2021-0,70ย โ‚ฌ-34.23%
2020-1,06ย โ‚ฌ-15.27%
2019-1,25ย โ‚ฌ-46.09%
2018-2,33ย โ‚ฌ9.95%
2017-2,12ย โ‚ฌ-3.49%
2016-2,19ย โ‚ฌ-10.19%
2015-2,44ย โ‚ฌ321.85%
2014-0,58ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-2,05ย โ‚ฌ 91.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-3,78ย โ‚ฌ 252.68%๐Ÿ‡บ๐Ÿ‡ธ USA